The efficacy and safety of 25 μg or 50 μg oral misoprostol versus 25 μg vaginal misoprostol given at 4‐ or 6‐hourly intervals for induction of labour in women at or beyond term with live singleton pregnancies: A systematic review and meta‐analysis
International Journal of Gynecology & Obstetrics · 2024
DOI: 10.1002/ijgo.14970 ↗Kurz gefasst
Metaanalyse in der Zeitschrift International Journal of Gynecology & Obstetrics, 2024. Verfasst von Hilda Yenuberi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Christian Medical College, Vellore, India. Hauptthemen laut MEDLINE: Misoprostol, Oxytocics, Perinatal Death. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Chistian medical college.
Abstract (Originalsprache)
Background
Misoprostol is widely used for cervical ripening and labour induction as it is heat‐stable and inexpensive. Oral misoprostol 25 μg given 2‐hourly is recommended over vaginal misoprostol 25 μg given 6‐hourly, but the need for 2‐hourly fetal monitoring makes oral misoprostol impractical for routine use in high‐volume obstetric units in resource‐constrained settings.
Objectives
To compare the efficacy and safety of oral misoprostol initiated at 25 or 50 μg versus 25 μg vaginal misoprostol given at 4‐ to 6‐hourly intervals for labor induction in women at or beyond term (≥ 37 weeks) with a single viable fetus and an unscarred uterus. Search Strategy We identified eligible randomized, parallel‐group, labor‐induction trials from recent systematic reviews. We additionally searched PubMed, Cochrane CENTRAL, Epistemonikos, and clinical trials registries from February 1, 2020 to December 31, 2022 without language restrictions. Database‐specific keywords for cervical priming, labor induction, and misoprostol were used. Selection Criteria We excluded labor‐induction trials exclusively in women with ruptured membranes, in the third trimester, and those that initiated misoprostol at doses not specified in the review's objectives. The primary outcomes were vaginal birth within 24 h, cesarean section, perinatal mortality, neonatal morbidity, and maternal morbidity. The secondary outcomes were uterine hyperstimulation with fetal heart rate changes, and oxytocin augmentation. Data Collection and Analysis Two or more authors selected studies independently, assessed risk of bias, and extracted data. We derived pooled weighted risk ratios with 95% confidence intervals (CIs) for each outcome, subgrouping trials by the dose and frequency of misoprostol regimens. We used the I 2 statistic to quantify heterogeneity and the random‐effects model for meta‐analysis when appropriate. We used the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) approach to assess certainty (confidence) in the effect estimates. Main Results Thirteen trials, from Canada, India, Iran, and the US, randomizing 2941 women at ≥37 weeks of gestation with an unfavorable cervix (Bishop score
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology, Christian Medical College, Vellore, India.
- Department of Community Health, Christian Medical College, Vellore, India.
- Clinical Epidemiology Unit, Christian Medical College, Vellore, India.
ORCID-Profile: Hilda Yenuberi, Jiji Mathews, Anne George, Santosh Benjamin, Swati Rathore, Richa Tirkey
Förderung
- Chistian medical college
Zitieren
APA
Yenuberi, H., Mathews, J., George, A., Benjamin, S., Rathore, S., Tirkey, R., & Tharyan, P. (2024). The efficacy and safety of 25 μg or 50 μg oral misoprostol versus 25 μg vaginal misoprostol given at 4‐ or 6‐hourly intervals for induction of labour in women at or beyond term with live singleton pregnancies: A systematic review and meta‐analysis. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.14970
Vancouver
Yenuberi H, Mathews J, George A, Benjamin S, Rathore S, Tirkey R, et al. The efficacy and safety of 25 μg or 50 μg oral misoprostol versus 25 μg vaginal misoprostol given at 4‐ or 6‐hourly intervals for induction of labour in women at or beyond term with live singleton pregnancies: A systematic review and meta‐analysis. International Journal of Gynecology & Obstetrics. 2024. doi:10.1002/ijgo.14970
BibTeX
@article{Yenuberi2024,
author = {Yenuberi, Hilda and Mathews, Jiji and George, Anne and Benjamin, Santosh and Rathore, Swati and Tirkey, Richa and Tharyan, Prathap},
title = {The efficacy and safety of 25 μg or 50 μg oral misoprostol versus 25 μg vaginal misoprostol given at 4‐ or 6‐hourly intervals for induction of labour in women at or beyond term with live singleton pregnancies: A systematic review and meta‐analysis},
journal = {International Journal of Gynecology & Obstetrics},
year = {2024},
doi = {10.1002/ijgo.14970}
}
EUVIMED